We respect your privacy. Please consent to all cookies when you visit our website. Refer to our "Privacy Policy" for more information on how we handle personal data.

Extractables_banner_pc_2x.webp Extractables_banner_ph_2x.webp

Pharmaceutical & Medical Device Testing (E&L, Sterility, Biocompatibility)

Milestone Pharma is your one-stop partner for pharmaceutical testing services and medical device testing, with integrated expertise in extractables and leachables testing, container closure integrity testing (CCIT), sterility assurance, and biocompatibility testing.

Overview

Milestone Pharma delivers end-to-end pharmaceutical testing services and medical device testing support across the full development lifecycle.

Our capabilities cover pharmaceutical packaging testing, extractables and leachables (E&L) studies, container closure integrity testing (CCIT), sterility assurance, biocompatibility testing, chemical characterization, and global regulatory support. Backed by ISO 17025-accredited laboratories and experience supporting submissions to the FDA, EU MDR, and NMPA, we help clients accelerate development with compliant, high-quality analytical data.

pharmaceuticalmedicaloverview2x.webp

Services

  • Medical Device Testing and Biocompatibility Testing
  • Sterility Assurance, CCIT, and Validation Services
  • Pharmaceutical Packaging Testing, E&L, and CCIT Services

Medical Device Testing and Biocompatibility Testing

From chemical characterization to toxicological risk assessment, our medical device testing and biocompatibility testing services support ISO 10993-based biological evaluation and performance assessment across a wide range of device categories.

Pharmaceutical Packaging Testing, E&L, and CCIT Services

From extractables and leachables (E&L) studies to container closure integrity testing (CCIT), pharmaceutical packaging testing, and global regulatory and DMF support, we provide end-to-end solutions across the full lifecycle of pharmaceutical packaging systems.

Feature Strengths

  • Regulatory Insight for Pharmaceutical and Medical Device Testing

    Our team brings deep knowledge of global regulatory expectations and industry guidance for pharmaceutical packaging testing, container closure integrity testing, sterility assurance, biocompatibility testing, and product quality studies.

    b2_strength_icon1_white.svg b5_strength_icon1.svg
  • Advanced Analytical and Testing Capability

    From chemical characterization and extractables and leachables testing to CCIT and microbiological testing, we deliver reliable, defensible data for complex pharmaceutical and medical device programs.

    b5_strength_icon2.svg b2_strength_icon2_blue.svg
  • Full-Lifecycle Support from Development to Registration

    We support pharmaceutical testing services and medical device testing projects from early development and method establishment through registration, commercialization, and post-approval change management.

    b5_strength_icon2.svg b2_strength_icon2_blue.svg

FAQ

  • What is the Maximum Allowable Leakage Limit (MALL)?

    The MALL is the leak rate that corresponds to the maximum leak size that could compromise sterility — typically considered to be approximately 0.1–1.0 μm for most sterile products. Our vacuum decay method (LOD 1 μm) can reliably detect leaks at or below the MALL for most applications.

  • Can you validate a CCIT method for my specific packaging?

    Yes. We develop and validate CCIT methods tailored to your specific packaging configuration. Validation includes sensitivity studies (spiked samples with known defect sizes), specificity testing, and correlation to microbial challenge data per USP <1207> recommendations.

  • How do I choose the right CCIT method for my product?

    The right CCIT method depends on your package type, product characteristics, required sensitivity, and regulatory expectations. Deterministic methods such as vacuum decay, helium leak detection, and HVLD are often preferred for their reproducibility and sensitivity, while challenge-based methods can support development or correlation studies.

  • What is the difference between deterministic and probabilistic container closure integrity testing (CCIT)?

    Deterministic container closure integrity testing (CCIT) methods such as vacuum decay, pressure decay, and helium leak detection produce quantitative, reproducible results with defined sensitivity limits. Probabilistic methods such as microbial challenge and dye ingress produce pass/fail outcomes with greater statistical variability. USP <1207> generally prefers deterministic methods for stronger scientific assurance.

  • How long does a pharmaceutical packaging E&L study usually take?

    A typical pharmaceutical packaging extractables and leachables (E&L) study takes about 8 to 16 weeks, depending on the packaging configuration, material complexity, study design, analytical method requirements, and toxicological risk assessment scope.

  • What is included in your extractables and leachables testing database?

    Our proprietary database contains over 1000 known packaging extractables with their chemical structures, analytical detection methods, and toxicological data. This enables rapid identification of detected compounds and streamlines the toxicological risk assessment process.

  • What is the difference between extractables and leachables in pharmaceutical packaging testing?

    Extractables are compounds that can be pulled from packaging materials under aggressive laboratory conditions. Leachables are compounds that actually migrate into the drug product under normal storage or use conditions. In practice, extractables studies define potential risk, while leachables studies confirm real product exposure.

Discuss My Project

Speak with an expert about your upcoming project to see how we can help you.